Huang Gui-Qian, Zhu Gui-Qi, Liu Yan-Long, Wang Li-Ren, Braddock Martin, Zheng Ming-Hua, Zhou Meng-Tao
Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Renji School of Wenzhou Medical University, Wenzhou 325000, China.
Oncotarget. 2016 Feb 2;7(5):5429-39. doi: 10.18632/oncotarget.6707.
Neutrophil lymphocyte ratio (NLR) has been shown to predict prognosis of cancers in several studies. This study was designed to evaluate the impact of stratified NLR in patients who have received curative liver resection (CLR) for hepatocellular carcinoma (HCC).
A total of 1659 patients who underwent CLR for suspected HCC between 2007 and 2014 were reviewed. The preoperative NLR was categorized into quartiles based on the quantity of the study population and the distribution of NLR. Hazard ratios (HRs) and 95% confidence intervals (CIs) were significantly associated with overall survival (OS) and derived by Cox proportional hazard regression analyses. Univariate and multivariate Cox proportional hazard regression analyses were evaluated for association of all independent parameters with disease prognosis.
Multivariable Cox proportional hazards models showed that the level of NLR (HR = 1.031, 95%CI: 1.002-1.060, P = 0.033), number of nodules (HR = 1.679, 95%CI: 1.285-2.194, P<0.001), portal vein thrombosis (HR = 4.329, 95%CI: 1.968-9.521, P<0.001), microvascular invasion (HR = 2.527, 95%CI: 1.726-3.700, P<0.001) and CTP score (HR = 1.675, 95%CI: 1.153-2.433, P = 0.007) were significant predictors of mortality. From the Kaplan-Meier analysis of overall survival (OS), each NLR quartile showed a progressively worse OS and apparent separation (log-rank P=0.008). The highest 5-year OS rate following CLR (60%) in HCC patients was observed in quartile 1. In contrast, the lowest 5-year OS rate (27%) was obtained in quartile 4.
Stratified NLR may predict significantly improved outcomes and strengthen the predictive power for patient responses to therapeutic intervention.
多项研究表明中性粒细胞与淋巴细胞比值(NLR)可预测癌症预后。本研究旨在评估分层NLR对接受肝细胞癌(HCC)根治性肝切除术(CLR)患者的影响。
回顾了2007年至2014年间因疑似HCC接受CLR的1659例患者。根据研究人群数量和NLR分布,将术前NLR分为四分位数。通过Cox比例风险回归分析得出风险比(HR)和95%置信区间(CI),其与总生存期(OS)显著相关。对所有独立参数与疾病预后的相关性进行单因素和多因素Cox比例风险回归分析。
多变量Cox比例风险模型显示,NLR水平(HR = 1.031,95%CI:1.002 - 1.060,P = 0.033)、结节数量(HR = 1.679,95%CI:1.285 - 2.194,P<0.001)、门静脉血栓形成(HR = 4.329,95%CI:1.968 - 9.521,P<0.001)、微血管侵犯(HR = 2.527,95%CI:1.726 - 3.700,P<0.001)和CTP评分(HR = 1.675,95%CI:1.153 - 2.433,P = 0.007)是死亡率的显著预测因素。从总生存期(OS)的Kaplan-Meier分析来看,每个NLR四分位数的OS均逐渐变差且有明显差异(对数秩检验P = 0.008)。HCC患者CLR后5年总生存率最高(60%)出现在第1四分位数。相比之下,第4四分位数的5年总生存率最低(27%)。
分层NLR可显著预测更好的预后,并增强对患者治疗反应的预测能力。